Filter Results:
(45)
Show Results For
- All HBS Web
(165)
- News (45)
- Research (98)
- Events (1)
- Multimedia (1)
- Faculty Publications (61)
Show Results For
- All HBS Web
(165)
- News (45)
- Research (98)
- Events (1)
- Multimedia (1)
- Faculty Publications (61)
Page 1 of 45
Results →
Sort by
- 18 Feb 2016
- News
Challenge Aims to Speed Drug Trials Process
clinical trials process. Today, it takes at least 10 years and billions of dollars for one FDA-approved drug to move from research labs to medicine cabinets. Precision medicine will bring faster innovation,... View Details
- 09 Nov 2011
- News
Resistance Is Futile
- 01 Oct 2011
- News
Resistance Is Futile
- 01 Dec 2023
- News
Wide Horizon
IP rights for suramin, a century-old drug historically used to treat African sleeping sickness, a parasitic disease, and later tested as a treatment for metastatic cancer. N of One had supported a trial by... View Details
Keywords: Dan Morrell; Photos by Sarah Wilson
- 07 Feb 2024
- News
The Sound of Success
A groundbreaking gene therapy developed by Akouos, Inc., a precision genetic medicine company founded in 2016 by Emmanuel (Manny) Simons (MBA 2012), has enabled an 11-year-old boy from Morocco to hear sounds for the first time. According to a recent New York Times... View Details
- 04 Apr 2024
- News
The Making of a Medical Milestone
How did Eledon get involved with the transplant case at MGH? We have multiple trials going on around the world, including at MGH. We have the most advanced novel drug in clinical development for transplant... View Details
Keywords: Margie Kelley
- 22 Feb 2024
- News
Combat-Tested Cancer Coaching
our scientists would have the tissue to play with. Then we started developing new drugs and new trials coming into the MMR. So now fast forward. Here we are, we have 15 drugs... View Details
- 31 Jan 2014
- News
Body, Heal Thyself
molecules responsible for transporting DNA code from a cell's nucleus to the ribosomes that create proteins. mRNA Therapeutics, as the company calls this new drug application, gives patients' cells the code they need to begin creating... View Details
- 31 May 2023
- News
Alumni Achievement Awards 2023
came to Vertex in 2017, there was a medicine finishing early clinical trials with the potential to serve up to 90 percent of patients with cystic fibrosis (CF). In October 2019 that became Trikafta. Now CF patients talk to me about... View Details
- 01 Jun 2023
- News
Research Brief: The Best Medicine
the clinical approval process. In a survey experiment, the researchers found that 72 percent of doctors had been asked by their patients whether a new drug would “work in people like me.” Black patients and the doctors who treat them put... View Details
- 16 Sep 2016
- News
Gaining Ground on ALS
Bucket Challenge to support the Phase 3 trial of a promising investigational drug that is designed to slow the loss of lung function and muscle strength in patients with ALS. “Clinical View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
20 years to get where we are,” shares Blum, “but the tradeoff is that today we have several very promising therapies that are in late-stage trials.” One of those therapies is tirasemtiv, the drug in the Phase 3 View Details
Keywords: Deborah Blagg
- 15 Dec 2024
- News
After Ozempic
Back before Ozempic, when Kate Mulroney (MBA 1984) spoke at technical conferences about her work at Novo Nordisk, people often assumed she was talking about Novartis. “I’d have to explain that’s a Swiss company; we’re Danish,” says Mulroney, now head of advanced... View Details
- 24 Sep 2020
- News
The Race for a Vaccine
Pisano says. But vaccines don’t really fit the same business model as high-volume therapeutic drugs; they have an even higher bar for safety and effectiveness, because unlike most other drugs they are administered to healthy populations.... View Details
- 20 Aug 2014
- News
With No Time to Lose
an effective biomarker—a kind of test that could measure the progression of ALS over a short period of time—did not yet exist. Without it, drug trials relied on longer, more costly observations of disease... View Details
Keywords: Margie Kelley